tiprankstipranks
Trending News
More News >
Ondine Biomedical, Inc. (GB:OBI)
LSE:OBI
UK Market
Advertisement

Ondine Biomedical, Inc. (OBI) Income Statement

Compare
12 Followers

Ondine Biomedical, Inc. Income Statement

Last quarter (Q2 2024), Ondine Biomedical, Inc.'s total revenue was C$865.23K, an increase of 248.66% from the same quarter last year. In Q2, Ondine Biomedical, Inc.'s net income was C$-7.82M. See Ondine Biomedical, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 2.05MC$ 1.20MC$ 638.00KC$ 2.57MC$ 1.79M
Gross Profit
C$ 1.32MC$ 703.00KC$ 287.00KC$ 1.25MC$ 649.00K
Operating Expenses
C$ 20.77MC$ 15.51MC$ 19.05MC$ 18.77MC$ 16.52M
Depreciation and Amortization
C$ 565.00KC$ 587.00KC$ 493.00KC$ 514.00KC$ 1.22M
EBITDA
C$ -18.49MC$ -13.79MC$ -18.85MC$ -48.36MC$ -14.56M
Operating Income
C$ -19.44MC$ -14.80MC$ -18.76MC$ -17.52MC$ -15.87M
Other Income/Expenses
C$ 346.00KC$ 393.00KC$ -609.00KC$ -32.56MC$ -400.00K
Pretax Income
C$ -19.10MC$ -14.41MC$ -19.37MC$ -50.09MC$ -16.21M
Net Income
C$ -19.10MC$ -14.41MC$ -19.37MC$ -50.09MC$ -16.27M
Per Share Metrics
Basic EPS
C$ -0.07C$ -0.07C$ -0.10C$ -0.26C$ -0.08
Diluted EPS
C$ -0.07C$ -0.07C$ -0.10C$ -0.26C$ -0.08
Weighted Average Shares Outstanding
274.60M 197.11M 194.59M 194.59M 194.59M
Weighted Average Shares Outstanding (Diluted)
274.60M 197.11M 194.59M 194.59M 194.59M
Currency in CAD

Ondine Biomedical, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis